首页 > 最新文献

Annals of Thoracic Medicine最新文献

英文 中文
The Saudi Thoracic Society Evidence-based guidelines for the diagnosis and management of chronic obstructive pulmonary disease. 沙特胸科学会慢性阻塞性肺疾病诊断和治疗循证指南
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-09-24 DOI: 10.4103/atm.atm_155_24
Hamdan Al-Jahdali, Riyad Al-Lehebi, Hani Lababidi, Faris F Alhejaili, Yahya Habis, Waleed A Alsowayan, Majdy M Idrees, Mohammed O Zeitouni, Abdullah Alshimemeri, Mohammed Al Ghobain, Ali Alaraj, Esam H Alhamad

The Saudi Thoracic Society (STS) developed an updated evidence-based guideline for diagnosing and managing chronic obstructive pulmonary disease (COPD) in Saudi Arabia. This guideline aims to provide a comprehensive and unbiased review of current evidence for assessing, diagnosing, and treating COPD. While epidemiological data on COPD in Saudi Arabia are limited, the STS panel believes that the prevalence is increasing due to rising rates of tobacco smoking. The key objectives of the guidelines are to facilitate accurate diagnosis of COPD, identify the risk for COPD exacerbations, and provide recommendations for relieving and reducing COPD symptoms in stable patients and during exacerbations. A unique aspect of this guideline is its simplified, practical approach to classifying patients into three classes based on symptom severity using the COPD Assessment Test and the risk of exacerbations and hospitalizations. The guideline provides the reader with an executive summary of recommended COPD treatments based on the best available evidence and also addresses other major aspects of COPD management and comorbidities. This guideline is primarily intended for use by internists and general practitioners in Saudi Arabia.

沙特胸科学会(STS)为沙特阿拉伯慢性阻塞性肺疾病(COPD)的诊断和管理制定了更新的循证指南。本指南旨在对评估、诊断和治疗COPD的现有证据进行全面、公正的回顾。虽然沙特阿拉伯COPD的流行病学数据有限,但STS小组认为,由于吸烟率上升,患病率正在上升。该指南的主要目标是促进COPD的准确诊断,确定COPD恶化的风险,并为缓解和减少稳定患者和恶化期间的COPD症状提供建议。该指南的一个独特之处在于其简化、实用的方法,将患者根据症状严重程度、COPD评估测试以及恶化和住院的风险分为三类。该指南为读者提供了基于现有最佳证据的推荐COPD治疗方法的执行摘要,并解决了COPD管理和合并症的其他主要方面。本指南主要供沙特阿拉伯的内科医生和全科医生使用。
{"title":"The Saudi Thoracic Society Evidence-based guidelines for the diagnosis and management of chronic obstructive pulmonary disease.","authors":"Hamdan Al-Jahdali, Riyad Al-Lehebi, Hani Lababidi, Faris F Alhejaili, Yahya Habis, Waleed A Alsowayan, Majdy M Idrees, Mohammed O Zeitouni, Abdullah Alshimemeri, Mohammed Al Ghobain, Ali Alaraj, Esam H Alhamad","doi":"10.4103/atm.atm_155_24","DOIUrl":"10.4103/atm.atm_155_24","url":null,"abstract":"<p><p>The Saudi Thoracic Society (STS) developed an updated evidence-based guideline for diagnosing and managing chronic obstructive pulmonary disease (COPD) in Saudi Arabia. This guideline aims to provide a comprehensive and unbiased review of current evidence for assessing, diagnosing, and treating COPD. While epidemiological data on COPD in Saudi Arabia are limited, the STS panel believes that the prevalence is increasing due to rising rates of tobacco smoking. The key objectives of the guidelines are to facilitate accurate diagnosis of COPD, identify the risk for COPD exacerbations, and provide recommendations for relieving and reducing COPD symptoms in stable patients and during exacerbations. A unique aspect of this guideline is its simplified, practical approach to classifying patients into three classes based on symptom severity using the COPD Assessment Test and the risk of exacerbations and hospitalizations. The guideline provides the reader with an executive summary of recommended COPD treatments based on the best available evidence and also addresses other major aspects of COPD management and comorbidities. This guideline is primarily intended for use by internists and general practitioners in Saudi Arabia.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"20 1","pages":"1-35"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence and influencing factors of high-flow nasal cannula humidified oxygen therapy in elderly patients with stable chronic obstructive pulmonary disease: A meta-analysis. 高龄稳定期慢性阻塞性肺疾病患者高流量鼻导管湿化氧治疗依从性及影响因素荟萃分析
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2025-01-11 DOI: 10.4103/atm.atm_151_24
Yang Yang, Ting-Ting Liu, Dong-Mei Li, Xue-Ling Ren, Zheng Luo, Xue-Li Chen, Ying-Zhen Du, Yan-Shuang Cheng

Objective: The objective of the study was to systematically evaluate and perform a meta-analysis on the adherence to high-flow nasal cannula (HFNC) humidified oxygen therapy and its influencing factors in elderly patients with stable chronic obstructive pulmonary disease (COPD).

Methods: Relevant literature on HFNC and COPD was retrieved from PubMed, EMbase, Web of Science, and Cochrane Library databases. Cross-sectional studies, case-control studies, and cohort studies were included. Screening and quality assessment were conducted using Endnote X9 software. Quality scores were assigned using the Newcastle-Ottawa Scale and the AHRQ assessment tool. Basic information, sample size, and adherence-related factors were extracted, and heterogeneity and publication bias were assessed.

Results: A total of 321 articles were initially identified, with 8 English articles involving 325 patients included after screening. Quality assessment yielded five high-quality articles (score > 8), two medium-quality articles (score = 7), and one low-quality article (score = 6). Meta-analysis results showed a COPD patient HFNC adherence rate of 32.7%. Negative factors included the number of acute exacerbations (odds ratio [OR] =2.17), adverse reactions (OR = 4.13), regular follow-up (OR = 9.45), educational level (OR = 5.38), and concurrent medications (OR = 4.71). Positive factors included age < 70 years (OR = 0.45), duration of use (OR = 0.30), inhalation technique (OR = 0.31), treatment satisfaction (OR = 0.35), and adverse reactions (OR = 0.15). Funnel plot and Egger's test results indicated minimal publication bias.

Conclusion: Adherence to HFNC in elderly COPD patients is relatively low, influenced by negative factors such as the number of acute exacerbations, adverse reactions, regular follow-up, educational level, and concurrent medications. Positive factors include age < 70 years, duration of use, inhalation technique, treatment satisfaction, and adverse reactions.

目的:系统评价高龄稳定期慢性阻塞性肺疾病(COPD)患者高流量鼻插管(HFNC)湿化氧治疗依从性及其影响因素,并进行meta分析。方法:从PubMed、EMbase、Web of Science和Cochrane Library数据库中检索HFNC和COPD的相关文献。包括横断面研究、病例对照研究和队列研究。使用Endnote X9软件进行筛选和质量评价。使用纽卡斯尔-渥太华量表和AHRQ评估工具分配质量分数。提取基本信息、样本量和依从性相关因素,并评估异质性和发表偏倚。结果:最初共纳入321篇文献,筛选后纳入8篇英文文献,涉及325例患者。质量评估获得5篇高质量文章(评分为bbb80), 2篇中等质量文章(评分为7),1篇低质量文章(评分为6)。meta分析结果显示COPD患者HFNC依从率为32.7%。负面因素包括急性加重次数(优势比[OR] =2.17)、不良反应(OR = 4.13)、定期随访(OR = 9.45)、文化程度(OR = 5.38)、并发用药(OR = 4.71)。阳性因素包括年龄< 70岁(OR = 0.45)、使用时间(OR = 0.30)、吸入技术(OR = 0.31)、治疗满意度(OR = 0.35)、不良反应(OR = 0.15)。漏斗图和Egger检验结果显示发表偏倚最小。结论:老年COPD患者HFNC依从性较低,受急性加重次数、不良反应、定期随访、文化程度、并发用药等不利因素影响。阳性因素包括年龄< 70岁、使用时间、吸入技术、治疗满意度和不良反应。
{"title":"Adherence and influencing factors of high-flow nasal cannula humidified oxygen therapy in elderly patients with stable chronic obstructive pulmonary disease: A meta-analysis.","authors":"Yang Yang, Ting-Ting Liu, Dong-Mei Li, Xue-Ling Ren, Zheng Luo, Xue-Li Chen, Ying-Zhen Du, Yan-Shuang Cheng","doi":"10.4103/atm.atm_151_24","DOIUrl":"10.4103/atm.atm_151_24","url":null,"abstract":"<p><strong>Objective: </strong>The objective of the study was to systematically evaluate and perform a meta-analysis on the adherence to high-flow nasal cannula (HFNC) humidified oxygen therapy and its influencing factors in elderly patients with stable chronic obstructive pulmonary disease (COPD).</p><p><strong>Methods: </strong>Relevant literature on HFNC and COPD was retrieved from PubMed, EMbase, Web of Science, and Cochrane Library databases. Cross-sectional studies, case-control studies, and cohort studies were included. Screening and quality assessment were conducted using Endnote X9 software. Quality scores were assigned using the Newcastle-Ottawa Scale and the AHRQ assessment tool. Basic information, sample size, and adherence-related factors were extracted, and heterogeneity and publication bias were assessed.</p><p><strong>Results: </strong>A total of 321 articles were initially identified, with 8 English articles involving 325 patients included after screening. Quality assessment yielded five high-quality articles (score > 8), two medium-quality articles (score = 7), and one low-quality article (score = 6). Meta-analysis results showed a COPD patient HFNC adherence rate of 32.7%. Negative factors included the number of acute exacerbations (odds ratio [OR] =2.17), adverse reactions (OR = 4.13), regular follow-up (OR = 9.45), educational level (OR = 5.38), and concurrent medications (OR = 4.71). Positive factors included age < 70 years (OR = 0.45), duration of use (OR = 0.30), inhalation technique (OR = 0.31), treatment satisfaction (OR = 0.35), and adverse reactions (OR = 0.15). Funnel plot and Egger's test results indicated minimal publication bias.</p><p><strong>Conclusion: </strong>Adherence to HFNC in elderly COPD patients is relatively low, influenced by negative factors such as the number of acute exacerbations, adverse reactions, regular follow-up, educational level, and concurrent medications. Positive factors include age < 70 years, duration of use, inhalation technique, treatment satisfaction, and adverse reactions.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"20 1","pages":"49-55"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracking continuous positive airway pressure adherence in obstructive sleep apnea patients before, during, and after the COVID-19 lockdown. 追踪阻塞性睡眠呼吸暂停患者在COVID-19封锁之前、期间和之后的持续气道正压依从性。
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-10-15 DOI: 10.4103/atm.atm_296_23
Abdulaziz O BaHammam, Fawaz Alhuqayl, Ibrahim Alzaid, Ziyad Alzammam, Faisal Alhuqayl, Bader Rajeh, Galal Eldin Abbas Eltayeb, Samar Nashwan, Salih Aleissi, Ahmed Salem BaHammam

Background: This study aimed to examine the impact of the COVID-19 lockdown on adherence to continuous positive airway pressure (CPAP) therapy among Saudi patients with obstructive sleep apnea (OSA). It also sought to assess the influence of demographic variables and comorbidities on CPAP adherence.

Methods: A prospective cohort study was conducted at the University Sleep Disorders Center at King Saud University Medical City. The study included 67 OSA patients who exclusively used CPAP for treatment across three distinct intervals: prelockdown, during lockdown, and postlockdown. Adherence to CPAP therapy was objectively measured using "mask-on on-time monitoring" data from the CPAP machines.

Results: The study found a significant decrease in the number of days with CPAP usage during the lockdown period, which persisted postlockdown. Approximately half of the patients adhered to CPAP treatment throughout the three study intervals. The decrease in CPAP usage days during lockdown was particularly noticeable among patients younger than 50 and older than 65 years of age. The presence of comorbidities, body mass index, and sex did not significantly influence CPAP treatment adherence.

Conclusion: The COVID-19 lockdown significantly impacted CPAP treatment adherence among OSA patients, with a decrease in adherence persisting postlockdown. This highlights the need for interventions to support CPAP adherence during challenging times such as a pandemic. Further research is needed to understand the long-term effects of the pandemic on CPAP therapy adherence.

背景:本研究旨在探讨 COVID-19 封锁对沙特阻塞性睡眠呼吸暂停(OSA)患者坚持持续气道正压(CPAP)治疗的影响。研究还试图评估人口统计学变量和合并症对坚持 CPAP 治疗的影响:沙特国王大学医疗城的大学睡眠障碍中心开展了一项前瞻性队列研究。该研究包括 67 名 OSA 患者,他们在三个不同的时间段内专门使用 CPAP 进行治疗:禁闭前、禁闭期间和禁闭后。使用 CPAP 机器的 "面罩开启时间监测 "数据对 CPAP 治疗的依从性进行了客观测量:研究发现,在封锁期间,使用 CPAP 的天数明显减少,封锁后这种情况依然存在。约有一半的患者在三个研究期间坚持使用 CPAP 治疗。封锁期间使用 CPAP 的天数减少在 50 岁以下和 65 岁以上的患者中尤为明显。合并症、体重指数和性别对坚持使用 CPAP 治疗没有明显影响:COVID-19封锁严重影响了OSA患者的CPAP治疗依从性,封锁后依从性持续下降。这凸显了在大流行等具有挑战性的时期采取干预措施支持患者坚持使用 CPAP 的必要性。要了解大流行对 CPAP 治疗依从性的长期影响,还需要进一步的研究。
{"title":"Tracking continuous positive airway pressure adherence in obstructive sleep apnea patients before, during, and after the COVID-19 lockdown.","authors":"Abdulaziz O BaHammam, Fawaz Alhuqayl, Ibrahim Alzaid, Ziyad Alzammam, Faisal Alhuqayl, Bader Rajeh, Galal Eldin Abbas Eltayeb, Samar Nashwan, Salih Aleissi, Ahmed Salem BaHammam","doi":"10.4103/atm.atm_296_23","DOIUrl":"10.4103/atm.atm_296_23","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to examine the impact of the COVID-19 lockdown on adherence to continuous positive airway pressure (CPAP) therapy among Saudi patients with obstructive sleep apnea (OSA). It also sought to assess the influence of demographic variables and comorbidities on CPAP adherence.</p><p><strong>Methods: </strong>A prospective cohort study was conducted at the University Sleep Disorders Center at King Saud University Medical City. The study included 67 OSA patients who exclusively used CPAP for treatment across three distinct intervals: prelockdown, during lockdown, and postlockdown. Adherence to CPAP therapy was objectively measured using \"mask-on on-time monitoring\" data from the CPAP machines.</p><p><strong>Results: </strong>The study found a significant decrease in the number of days with CPAP usage during the lockdown period, which persisted postlockdown. Approximately half of the patients adhered to CPAP treatment throughout the three study intervals. The decrease in CPAP usage days during lockdown was particularly noticeable among patients younger than 50 and older than 65 years of age. The presence of comorbidities, body mass index, and sex did not significantly influence CPAP treatment adherence.</p><p><strong>Conclusion: </strong>The COVID-19 lockdown significantly impacted CPAP treatment adherence among OSA patients, with a decrease in adherence persisting postlockdown. This highlights the need for interventions to support CPAP adherence during challenging times such as a pandemic. Further research is needed to understand the long-term effects of the pandemic on CPAP therapy adherence.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"20 1","pages":"56-61"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804958/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertension. 特发性肺动脉高压患者血管反应性检测的流行及特点。
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2025-01-11 DOI: 10.4103/atm.atm_189_24
Goncharova Natalia, Kirill Lapshin, Aelita Berezina, Irina Zlobina, Anton Ryzhkov, Zhaneta Matakaeva, Elizaveta Andreeva, Olga Moiseeva

Introduction: The choice of treatment strategy in patients with idiopathic pulmonary arterial hypertension (IPAH)/HPAH/DPAH (Hereditary pulmonary arterial hypertension/ Drug-induced pulmonary arterial hypertension) II-III functional class (FC) (WHO) based on an acute vasoreactive testing result (VRT). Positive VRT (VRT+) is an indication for calcium channel blockers therapy. Long-term vasoresponders demonstrate sustained low-risk status and the highest survival among all PH subtypes.

The study aimed: To characterize VRT performance in IPAH patients and differences in presentation between patients with positive, negative VRT, and patients with not done VRT due to physicians' decision.

Methods: One hundred and sixty-six adult IPAH patients (44.2 ± 15.3 years, 34 males) comprised into prospective single-center study between 2008 and 2023 years. Inhaled iloprost was used for VRT. Positive VRT was defined with established Sitbon criteria. Standard baseline pulmonary arterial hypertension (PAH) evaluation including cardiopulmonary exercise test (CPET) was performed. Risk status was evaluated using ESC/ERS (European Society of Cardiology/European Respiratory Society) risk scale 2015. Survival was assessed with the Kaplan-Mayer method.

Results: Eighty-five (51.2%) patients underwent VRT. VRT not done (ND VRT) due to the physicians' decision in 26.7% patients, due to the technical inability in 15.4% and IV FC (WHO) in 16.2% patients. Positive VRT registered in 26 (15.6%) patients. Patients with negative VRT demonstrated worse hemodynamics and exercise tolerance, higher N-terminal pro-brain-type natriuretic peptide (NT-proBNP) level, and right heart dilatation compared with VRT+. Patients with ND VRT due to the physicians decision were often older than 60 years, had higher body mass index, symptoms of right heart failure, hemoptysis, arrhythmias, high NT-proBNP, and hemodynamic criteria of high risk in comparison with patients with done VRT. Some CPET parameters were similar between VRT + group and patients ND VRT group. Loss of vasoreactivity and PAH worsening were detected in 50% of VRT + patients in a 1.76 year of follow-up. Patients with vasoreactivity loss exhibited the criteria of intermediate risk at a baseline. Five-year survival was 97% in VRT + group in comparison with 61% in VRT - and 53% in ND VRT group.

Conclusions: Physicians' decision was the most common reason for not doing VRT in IPAH patients. Intermediate high-risk criteria presence at a baseline were associated with not done VRT due to physicians decision, negative VRT, and the vasoreactivity loss during the follow-up. CPET should be used more widely to detect the early signs of PAH progression in low risk or VRT + patients.

基于急性血管反应试验结果(VRT)的特发性肺动脉高压(IPAH)/HPAH/DPAH(遗传性肺动脉高压/药物性肺动脉高压)II-III功能分类(FC) (WHO)患者治疗策略的选择。VRT阳性(VRT+)是钙通道阻滞剂治疗的指征。在所有PH亚型中,长期血管应答者表现出持续的低风险状态和最高的生存率。该研究的目的是:表征IPAH患者的VRT表现,以及VRT阳性、阴性和因医生决定未进行VRT的患者之间的表现差异。方法:2008 - 2023年间,166例IPAH成年患者(44.2±15.3岁,男性34例)纳入前瞻性单中心研究。VRT采用吸入伊洛前列素。VRT阳性以既定的Sitbon标准定义。进行标准基线肺动脉高压(PAH)评估,包括心肺运动试验(CPET)。使用ESC/ERS(欧洲心脏病学会/欧洲呼吸学会)2015年风险量表评估风险状态。采用Kaplan-Mayer法评估生存率。结果:85例(51.2%)患者行VRT治疗。26.7%的患者由于医生的决定而未做VRT (ND VRT), 15.4%的患者由于技术上的无能,16.2%的患者由于IV FC (WHO)。26例(15.6%)患者VRT阳性。与VRT+相比,VRT阴性患者血流动力学和运动耐量更差,n端脑型利钠肽(NT-proBNP)水平更高,右心扩张。与已完成VRT的患者相比,由于医生的决定而进行ND VRT的患者通常年龄大于60岁,具有较高的体重指数、右心衰症状、呕血、心律失常、高NT-proBNP和高危血流动力学标准。VRT +组与ND VRT组的CPET参数相似。在1.76年的随访中,50%的VRT +患者出现血管反应性丧失和PAH恶化。血管反应性丧失的患者在基线上表现为中度危险标准。VRT +组5年生存率为97%,VRT -组为61%,无VRT组为53%。结论:医生的决定是IPAH患者不做VRT的最常见原因。基线时存在的中等高危标准与由于医生的决定而未进行VRT、VRT阴性和随访期间血管反应性丧失有关。CPET应该更广泛地用于检测低风险或VRT +患者PAH进展的早期迹象。
{"title":"Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertension.","authors":"Goncharova Natalia, Kirill Lapshin, Aelita Berezina, Irina Zlobina, Anton Ryzhkov, Zhaneta Matakaeva, Elizaveta Andreeva, Olga Moiseeva","doi":"10.4103/atm.atm_189_24","DOIUrl":"10.4103/atm.atm_189_24","url":null,"abstract":"<p><strong>Introduction: </strong>The choice of treatment strategy in patients with idiopathic pulmonary arterial hypertension (IPAH)/HPAH/DPAH (Hereditary pulmonary arterial hypertension/ Drug-induced pulmonary arterial hypertension) II-III functional class (FC) (WHO) based on an acute vasoreactive testing result (VRT). Positive VRT (VRT+) is an indication for calcium channel blockers therapy. Long-term vasoresponders demonstrate sustained low-risk status and the highest survival among all PH subtypes.</p><p><strong>The study aimed: </strong>To characterize VRT performance in IPAH patients and differences in presentation between patients with positive, negative VRT, and patients with not done VRT due to physicians' decision.</p><p><strong>Methods: </strong>One hundred and sixty-six adult IPAH patients (44.2 ± 15.3 years, 34 males) comprised into prospective single-center study between 2008 and 2023 years. Inhaled iloprost was used for VRT. Positive VRT was defined with established Sitbon criteria. Standard baseline pulmonary arterial hypertension (PAH) evaluation including cardiopulmonary exercise test (CPET) was performed. Risk status was evaluated using ESC/ERS (European Society of Cardiology/European Respiratory Society) risk scale 2015. Survival was assessed with the Kaplan-Mayer method.</p><p><strong>Results: </strong>Eighty-five (51.2%) patients underwent VRT. VRT not done (ND VRT) due to the physicians' decision in 26.7% patients, due to the technical inability in 15.4% and IV FC (WHO) in 16.2% patients. Positive VRT registered in 26 (15.6%) patients. Patients with negative VRT demonstrated worse hemodynamics and exercise tolerance, higher N-terminal pro-brain-type natriuretic peptide (NT-proBNP) level, and right heart dilatation compared with VRT+. Patients with ND VRT due to the physicians decision were often older than 60 years, had higher body mass index, symptoms of right heart failure, hemoptysis, arrhythmias, high NT-proBNP, and hemodynamic criteria of high risk in comparison with patients with done VRT. Some CPET parameters were similar between VRT + group and patients ND VRT group. Loss of vasoreactivity and PAH worsening were detected in 50% of VRT + patients in a 1.76 year of follow-up. Patients with vasoreactivity loss exhibited the criteria of intermediate risk at a baseline. Five-year survival was 97% in VRT + group in comparison with 61% in VRT - and 53% in ND VRT group.</p><p><strong>Conclusions: </strong>Physicians' decision was the most common reason for not doing VRT in IPAH patients. Intermediate high-risk criteria presence at a baseline were associated with not done VRT due to physicians decision, negative VRT, and the vasoreactivity loss during the follow-up. CPET should be used more widely to detect the early signs of PAH progression in low risk or VRT + patients.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"20 1","pages":"62-70"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804955/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of surgery on survival of patients with small-cell lung cancer undiagnosed before resection. 手术对切除前未确诊的小细胞肺癌患者生存期的影响。
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-10-03 DOI: 10.4103/atm.atm_42_24
Brice Caput, Laura Peretti, Stephanie Lacomme, Angelica Tiotiu

Background: Standards of treatment for limited-stage small-cell lung cancer (SCLC) include chemoradiotherapy. The place of the surgery in this indication is still debated. The objective of this study was to evaluate the overall survival (OS) in patients who underwent surgery for an SCLC undiagnosed before resection in the University Hospital of Nancy, France. Secondarily, the impact of surgery on recurrence-free survival (RFS) was analyzed.

Methods: All the patients who underwent lung resection in the Department of Thoracic Surgery, from 1991 to 2018, and a diagnosis of SCLC after surgery were included. OS and RFS were analyzed according to the resection type, postoperative staging, and lymph node extension.

Results: Sixty-one patients were included. The median OS was higher in patients with lobectomy than those with pneumonectomy (26 [8.4-208.7] vs. 12 [3.4-27.6] months, P < 0.001) in stage I compared to other stages (58 [8.4-208.7] vs. 17 [3.4-83.5] months, P = 0.002), and N0-1 than N2 (25 [3.6-208.7] vs. 15 [3.4-83.5] months, P = 0.01). RFS was also significantly higher after lobectomy than after pneumonectomy (17 [1.6-184.9] vs. 8 [0.5-17.6], P < 0.001), stage I than stages II-III (35 [5-184.9] vs. 11 [0.5-42.4], P < 0.001) and N0-1 compared to N2 (25 [1.6-184.9] vs. 9 [0.5-16.5] months, P = 0.006). In multivariate analysis, the only independent factor influencing the OS was the pneumonectomy (hazard ratios = 3.19; 95% confidence interval [1.46-6.98], P = 0.004).

Conclusion: Surgical resection of stage I SCLC may lead to better OS and RFS. N1 patients should not automatically be excluded from surgery. Lobectomy with regional lymph node resection is the preferable choice of surgery.

背景:局限期小细胞肺癌(SCLC)的治疗标准包括放化疗。手术治疗在这一适应症中的地位仍存在争议。本研究旨在评估法国南锡大学医院因切除前未确诊的小细胞肺癌而接受手术治疗的患者的总生存率(OS)。其次,分析手术对无复发生存率(RFS)的影响:方法:纳入1991年至2018年期间在胸外科接受肺切除术、术后诊断为SCLC的所有患者。根据切除类型、术后分期和淋巴结扩展情况分析OS和RFS:结果:共纳入61例患者。肺叶切除术患者的中位OS高于肺切除术患者(26 [8.4-208.7] 个月 vs. 12 [3.4-27.6] 个月,P < 0.001),I期患者的中位OS高于其他分期患者(58 [8.4-208.7] 个月 vs. 17 [3.4-83.5] 个月,P = 0.002),N0-1期患者的中位OS高于N2期患者(25 [3.6-208.7] 个月 vs. 15 [3.4-83.5] 个月,P = 0.01)。肺叶切除术后的RFS也明显高于肺切除术后(17 [1.6-184.9] vs. 8 [0.5-17.6],P < 0.001),I期明显高于II-III期(35 [5-184.9] vs. 11 [0.5-42.4],P < 0.001),N0-1明显高于N2(25 [1.6-184.9] vs. 9 [0.5-16.5]个月,P = 0.006)。在多变量分析中,影响OS的唯一独立因素是肺切除术(危险比=3.19;95%置信区间[1.46-6.98],P=0.004):结论:I期SCLC的手术切除可改善OS和RFS。N1期患者不应自动被排除在手术之外。肺叶切除加区域淋巴结切除术是较好的手术选择。
{"title":"Effect of surgery on survival of patients with small-cell lung cancer undiagnosed before resection.","authors":"Brice Caput, Laura Peretti, Stephanie Lacomme, Angelica Tiotiu","doi":"10.4103/atm.atm_42_24","DOIUrl":"10.4103/atm.atm_42_24","url":null,"abstract":"<p><strong>Background: </strong>Standards of treatment for limited-stage small-cell lung cancer (SCLC) include chemoradiotherapy. The place of the surgery in this indication is still debated. The objective of this study was to evaluate the overall survival (OS) in patients who underwent surgery for an SCLC undiagnosed before resection in the University Hospital of Nancy, France. Secondarily, the impact of surgery on recurrence-free survival (RFS) was analyzed.</p><p><strong>Methods: </strong>All the patients who underwent lung resection in the Department of Thoracic Surgery, from 1991 to 2018, and a diagnosis of SCLC after surgery were included. OS and RFS were analyzed according to the resection type, postoperative staging, and lymph node extension.</p><p><strong>Results: </strong>Sixty-one patients were included. The median OS was higher in patients with lobectomy than those with pneumonectomy (26 [8.4-208.7] vs. 12 [3.4-27.6] months, <i>P</i> < 0.001) in stage I compared to other stages (58 [8.4-208.7] vs. 17 [3.4-83.5] months, <i>P</i> = 0.002), and N0-1 than N2 (25 [3.6-208.7] vs. 15 [3.4-83.5] months, <i>P</i> = 0.01). RFS was also significantly higher after lobectomy than after pneumonectomy (17 [1.6-184.9] vs. 8 [0.5-17.6], <i>P</i> < 0.001), stage I than stages II-III (35 [5-184.9] vs. 11 [0.5-42.4], <i>P</i> < 0.001) and N0-1 compared to N2 (25 [1.6-184.9] vs. 9 [0.5-16.5] months, <i>P</i> = 0.006). In multivariate analysis, the only independent factor influencing the OS was the pneumonectomy (hazard ratios = 3.19; 95% confidence interval [1.46-6.98], <i>P</i> = 0.004).</p><p><strong>Conclusion: </strong>Surgical resection of stage I SCLC may lead to better OS and RFS. N1 patients should not automatically be excluded from surgery. Lobectomy with regional lymph node resection is the preferable choice of surgery.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"19 4","pages":"258-265"},"PeriodicalIF":2.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the Arabic version of the Obstructive Sleep Apnea-18 quality of life questionnaire for evaluating children with sleep apnea-hypopnea syndrome. 阿拉伯语版 "阻塞性睡眠呼吸暂停-18 "生活质量问卷的验证,用于评估患有睡眠呼吸暂停-低通气综合征的儿童。
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-10-03 DOI: 10.4103/atm.atm_94_24
Montaha Al-Iede, Mohammad Ali Alshrouf, Abdallah Al-Ani, Alaa Alkurdi, Areej H Jaber, Omar Husain, Batool Abusabra, Nihad A Almasri

Background: Pediatric obstructive sleep apnea (OSA) poses a significant health concern, affecting the well-being and quality of life of affected children. This study focuses on the translation, adaptation, and validation of the OSA-18 questionnaire for Arabic-speaking pediatric patients, aiming to contribute to the understanding of OSA and its implications on the quality of life in this population.

Methods: A study was conducted at Jordan University Hospital, involving 186 Arabic-speaking pediatric patients with suspected OSA. The OSA-18 questionnaire was translated and culturally adapted following the World Health Organization guidelines. Overnight polysomnography was conducted to assess OSA severity. Internal consistency, construct validity, convergent validity, and predictive/discriminant validity were analyzed.

Results: The study sample (68.8% of males, median age: 10.87) showed a median Apnea-Hypopnea Index (AHI) of 7.0, OSA-18 score of 46.5, and Pediatric Sleep Questionnaire (PSQ) score of 7.0. Internal consistency of OSA-18 was acceptable, except for the "physical symptoms" domain. Exploratory and confirmatory factor analyses revealed five factors corresponding to different OSA-18 domains. Convergent validity was supported by significant correlations between OSA-18 and PSQ scores. However, no correlation was found between OSA-18 scores and AHI. OSA severity was associated with higher PSQ scores but not with AHI.

Conclusion: This study provides valuable insights into pediatric OSA in Arabic-speaking children. While the translation and validation of the OSA-18 questionnaire demonstrated acceptable reliability and convergent validity, the lack of correlation between OSA-18 scores and AHI raises questions about the survey's ability to capture the full impact of OSA objectively. Future research should focus on developing more reliable diagnostic tools, especially in resource-limited settings.

背景:小儿阻塞性睡眠呼吸暂停(OSA)是一个重大的健康问题,影响着患儿的健康和生活质量。本研究的重点是翻译、改编和验证阿拉伯语儿科患者的 OSA-18 问卷,旨在帮助了解 OSA 及其对该人群生活质量的影响:约旦大学医院开展了一项研究,涉及 186 名疑似 OSA 的阿拉伯语儿科患者。根据世界卫生组织的指导方针,对 OSA-18 问卷进行了翻译和文化调整。采用夜间多导睡眠图评估 OSA 的严重程度。对问卷的内部一致性、结构效度、收敛效度和预测/鉴别效度进行了分析:研究样本(68.8% 为男性,年龄中位数为 10.87 岁)的呼吸暂停-低通气指数(AHI)中位数为 7.0,OSA-18 评分为 46.5,儿科睡眠问卷(PSQ)评分为 7.0。除 "身体症状 "领域外,OSA-18 的内部一致性均可接受。探索性和确认性因子分析显示,有五个因子与 OSA-18 的不同领域相对应。OSA-18 和 PSQ 分数之间的显著相关性支持了收敛有效性。然而,OSA-18 评分与 AHI 之间没有相关性。OSA严重程度与较高的PSQ评分相关,但与AHI无关:本研究为阿拉伯语儿童的小儿 OSA 提供了宝贵的见解。虽然 OSA-18 问卷的翻译和验证显示了可接受的可靠性和收敛效度,但 OSA-18 分数与 AHI 之间缺乏相关性,这让人怀疑该调查能否客观地反映 OSA 的全部影响。未来的研究应侧重于开发更可靠的诊断工具,尤其是在资源有限的环境中。
{"title":"Validation of the Arabic version of the Obstructive Sleep Apnea-18 quality of life questionnaire for evaluating children with sleep apnea-hypopnea syndrome.","authors":"Montaha Al-Iede, Mohammad Ali Alshrouf, Abdallah Al-Ani, Alaa Alkurdi, Areej H Jaber, Omar Husain, Batool Abusabra, Nihad A Almasri","doi":"10.4103/atm.atm_94_24","DOIUrl":"10.4103/atm.atm_94_24","url":null,"abstract":"<p><strong>Background: </strong>Pediatric obstructive sleep apnea (OSA) poses a significant health concern, affecting the well-being and quality of life of affected children. This study focuses on the translation, adaptation, and validation of the OSA-18 questionnaire for Arabic-speaking pediatric patients, aiming to contribute to the understanding of OSA and its implications on the quality of life in this population.</p><p><strong>Methods: </strong>A study was conducted at Jordan University Hospital, involving 186 Arabic-speaking pediatric patients with suspected OSA. The OSA-18 questionnaire was translated and culturally adapted following the World Health Organization guidelines. Overnight polysomnography was conducted to assess OSA severity. Internal consistency, construct validity, convergent validity, and predictive/discriminant validity were analyzed.</p><p><strong>Results: </strong>The study sample (68.8% of males, median age: 10.87) showed a median Apnea-Hypopnea Index (AHI) of 7.0, OSA-18 score of 46.5, and Pediatric Sleep Questionnaire (PSQ) score of 7.0. Internal consistency of OSA-18 was acceptable, except for the \"physical symptoms\" domain. Exploratory and confirmatory factor analyses revealed five factors corresponding to different OSA-18 domains. Convergent validity was supported by significant correlations between OSA-18 and PSQ scores. However, no correlation was found between OSA-18 scores and AHI. OSA severity was associated with higher PSQ scores but not with AHI.</p><p><strong>Conclusion: </strong>This study provides valuable insights into pediatric OSA in Arabic-speaking children. While the translation and validation of the OSA-18 questionnaire demonstrated acceptable reliability and convergent validity, the lack of correlation between OSA-18 scores and AHI raises questions about the survey's ability to capture the full impact of OSA objectively. Future research should focus on developing more reliable diagnostic tools, especially in resource-limited settings.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"19 4","pages":"266-274"},"PeriodicalIF":2.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the public knowledge, attitude, and practice toward screening and risk factors of lung cancer in Saudi Arabia: A cross-sectional study. 了解沙特阿拉伯公众对肺癌筛查和风险因素的认识、态度和做法:横断面研究。
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-10-03 DOI: 10.4103/atm.atm_111_24
Sadin Ayman Alamri, Manal Mutlaq Alzahrani, Aseel Ayman Alamri, Waad Waleed Khalifa, Ruba Yosof Alsulami, Jameel Bardesi, Wed Salah, Abeer F Zakariyah

Context: Early detection of lung cancer through screening can improve outcomes; yet public knowledge, attitudes, and practices regarding lung cancer screening in Saudi Arabia are limited.

Aims: The aim is to assess knowledge, attitudes, and practices toward lung cancer risk factors and screening, and understand the impact of demographic factors on these variables.

Settings and design: An observational cross-sectional study was conducted from October 2023 to March 2024, involving 708 participants.

Methods: A validated questionnaire from a previous Malaysian study, translated into Arabic, was distributed to participants.

Statistical analysis used: Descriptive statistics, Shapiro-Wilk test, one-way analysis of variance, Tukey's test, and logistic regression were used.

Results: Most participants (95.9%) recognized smoking as a major risk factor. Common misconceptions included viewing lung cancer as infectious (84.0%) or affecting only men (14.4%). Nonetheless, 66.4% expressed willingness for future screening. Younger participants (18-40 years) and those with higher education demonstrated better knowledge scores (mean score: 11.33 ± 2.97 for ages 18-40; 11.42 ± 2.88 for those with master's or doctorate degrees), with significant differences based on age (P = 0.007) and education level (P = 0.025). No significant differences were observed based on gender, region of residence, or monthly family income.

Conclusions: There is a positive inclination toward lung cancer screening among the Saudi public, but there are significant knowledge gaps, particularly regarding nonsmoking-related risk factors and misconceptions, suggesting a need for enhanced public education and screening programs.

背景:通过筛查及早发现肺癌可以改善预后;然而,沙特阿拉伯公众对肺癌筛查的了解、态度和做法都很有限。目的:本研究旨在评估公众对肺癌风险因素和筛查的了解、态度和做法,并了解人口统计因素对这些变量的影响:一项观察性横断面研究于 2023 年 10 月至 2024 年 3 月进行,共有 708 人参与:方法:向参与者分发了一份经过验证的调查问卷,该问卷来自之前的一项马来西亚研究,并被翻译成阿拉伯语:使用了描述性统计、Shapiro-Wilk 检验、单因素方差分析、Tukey's 检验和逻辑回归:大多数参与者(95.9%)认为吸烟是一个主要风险因素。常见的误解包括将肺癌视为传染性疾病(84.0%)或只影响男性(14.4%)。尽管如此,66.4%的人表示愿意接受未来的筛查。年轻参与者(18-40 岁)和受教育程度较高者的知识得分更高(平均得分:18-40 岁为 11.33 ± 2.97;硕士或博士学位者为 11.42 ± 2.88),年龄(P = 0.007)和受教育程度(P = 0.025)差异显著。性别、居住地区或家庭月收入无明显差异:结论:沙特公众对肺癌筛查有积极的倾向,但存在很大的知识差距,尤其是与非吸烟相关的风险因素和误解,这表明需要加强公众教育和筛查计划。
{"title":"Understanding the public knowledge, attitude, and practice toward screening and risk factors of lung cancer in Saudi Arabia: A cross-sectional study.","authors":"Sadin Ayman Alamri, Manal Mutlaq Alzahrani, Aseel Ayman Alamri, Waad Waleed Khalifa, Ruba Yosof Alsulami, Jameel Bardesi, Wed Salah, Abeer F Zakariyah","doi":"10.4103/atm.atm_111_24","DOIUrl":"10.4103/atm.atm_111_24","url":null,"abstract":"<p><strong>Context: </strong>Early detection of lung cancer through screening can improve outcomes; yet public knowledge, attitudes, and practices regarding lung cancer screening in Saudi Arabia are limited.</p><p><strong>Aims: </strong>The aim is to assess knowledge, attitudes, and practices toward lung cancer risk factors and screening, and understand the impact of demographic factors on these variables.</p><p><strong>Settings and design: </strong>An observational cross-sectional study was conducted from October 2023 to March 2024, involving 708 participants.</p><p><strong>Methods: </strong>A validated questionnaire from a previous Malaysian study, translated into Arabic, was distributed to participants.</p><p><strong>Statistical analysis used: </strong>Descriptive statistics, Shapiro-Wilk test, one-way analysis of variance, Tukey's test, and logistic regression were used.</p><p><strong>Results: </strong>Most participants (95.9%) recognized smoking as a major risk factor. Common misconceptions included viewing lung cancer as infectious (84.0%) or affecting only men (14.4%). Nonetheless, 66.4% expressed willingness for future screening. Younger participants (18-40 years) and those with higher education demonstrated better knowledge scores (mean score: 11.33 ± 2.97 for ages 18-40; 11.42 ± 2.88 for those with master's or doctorate degrees), with significant differences based on age (<i>P</i> = 0.007) and education level (<i>P</i> = 0.025). No significant differences were observed based on gender, region of residence, or monthly family income.</p><p><strong>Conclusions: </strong>There is a positive inclination toward lung cancer screening among the Saudi public, but there are significant knowledge gaps, particularly regarding nonsmoking-related risk factors and misconceptions, suggesting a need for enhanced public education and screening programs.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"19 4","pages":"275-283"},"PeriodicalIF":2.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoadjuvant immunotherapy for lung cancer and hilar fibrosis during thoracoscopic lobectomy: Can we improve postoperative outcomes? 胸腔镜肺叶切除术中肺癌和肺门纤维化的新辅助免疫疗法:我们能改善术后效果吗?
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-10-03 DOI: 10.4103/atm.atm_125_24
Dario Amore, Dino Casazza, Umberto Caterino, Danilo Rocco, Carlo Bergaminelli
{"title":"Neoadjuvant immunotherapy for lung cancer and hilar fibrosis during thoracoscopic lobectomy: Can we improve postoperative outcomes?","authors":"Dario Amore, Dino Casazza, Umberto Caterino, Danilo Rocco, Carlo Bergaminelli","doi":"10.4103/atm.atm_125_24","DOIUrl":"10.4103/atm.atm_125_24","url":null,"abstract":"","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"19 4","pages":"295-296"},"PeriodicalIF":2.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559699/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142636189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the dynamic relationship of sleep-disordered breathing, orthodontic treatment needs, and dental esthetics in the general population. 调查普通人群中睡眠呼吸障碍、正畸治疗需求和牙齿美学之间的动态关系。
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-10-03 DOI: 10.4103/atm.atm_53_24
Dipasha K Rao, Bhagyalakshmi Avinash, T M Amulya, B S Prakash, N Raghunath, Vidya G Doddawad

Background: Sleep-disordered breathing (SDB) is characterized by upper airway dysfunction and is linked to severe health issues. Individuals with SDB have distinct craniofacial morphology for which orthodontists are most suitable for the management due to their dental expertise.

Aim: This study aims to discern key differences in dental parameters between individuals with and without SDB.

Methods: The present study is a cross-sectional observational study conducted for 12 months. Out of 70 participants, 35 were placed in the SDB group as per the Berlin questionnaire (BQ) and 35 in the control aged 18-22 years. Criteria excluded individuals with preexisting illnesses, missing teeth, tonsillectomy, orthodontic or jaw surgeries, cleft lip/palate, or craniofacial anomalies. Dental assessments included interdental width, palatal vault depth and shape, molar relation, overjet, and overbite. In addition, self-perceived orthodontic treatment needs were evaluated as a secondary measure.

Results: In the SDB group, interdental distances were significantly reduced in the canine, first premolars, second premolars, and molar regions by 2, 3, 4, and 1.8 mm, respectively. A noticeable V-shaped arch was observed. Overjet and overbite increased by 42.85% and 31.42%, respectively, with Class 1 malocclusion more prevalent than Class 2. The Berlin questionnaire identified 54.3% as high-risk SDB. The Index of Orthodontic Treatment Need-Esthetic Component (IOTN-AC) revealed that 68.6% of snoring participants required orthodontic treatment.

Conclusion: Individuals with SDB exhibit a constricted maxilla and reduced interdental measurements, indicating a moderate risk. The Berlin questionnaire proves valuable in assessing SDB severity. Moreover, individuals displaying signs of SDB often present a high prevalence of orthodontic treatment needs, as indicated by the IOTN-AC.

背景:睡眠呼吸障碍(SDB)以上呼吸道功能障碍为特征,与严重的健康问题相关。SDB患者的颅面形态与众不同,正畸医生因其牙科专业知识而最适合对其进行管理。目的:本研究旨在发现SDB患者与非SDB患者在牙科参数上的主要差异:本研究是一项横断面观察研究,为期 12 个月。在 70 名参与者中,根据柏林问卷调查(BQ),35 人属于 SDB 组,35 人属于对照组,年龄在 18-22 岁之间。研究标准排除了患有先天性疾病、牙齿缺失、扁桃体切除术、正畸或颌骨手术、唇腭裂或颅面畸形的患者。牙齿评估包括齿间宽度、腭穹深度和形状、臼齿关系、过咬合和过咬合。此外,还对自我感觉的正畸治疗需求进行了评估,作为次要衡量标准:结果:在 SDB 组中,犬齿、第一前磨牙、第二前磨牙和臼齿区域的齿间距离分别明显缩短了 2、3、4 和 1.8 毫米。观察到明显的 V 形牙弓。过牙合和过咬合分别增加了 42.85% 和 31.42%,第一类错合畸形比第二类更为普遍。柏林问卷调查显示,54.3%的人属于高危SDB。正畸治疗需求指数(IOTN-AC)显示,68.6%的打鼾参与者需要进行正畸治疗:结论:SDB 患者表现出上颌骨收缩和牙间隙缩小,这表明他们有中度风险。柏林问卷在评估 SDB 严重程度方面很有价值。此外,正如 IOTN-AC 所显示的那样,显示出 SDB 症状的人通常有较高的正畸治疗需求。
{"title":"Investigating the dynamic relationship of sleep-disordered breathing, orthodontic treatment needs, and dental esthetics in the general population.","authors":"Dipasha K Rao, Bhagyalakshmi Avinash, T M Amulya, B S Prakash, N Raghunath, Vidya G Doddawad","doi":"10.4103/atm.atm_53_24","DOIUrl":"10.4103/atm.atm_53_24","url":null,"abstract":"<p><strong>Background: </strong>Sleep-disordered breathing (SDB) is characterized by upper airway dysfunction and is linked to severe health issues. Individuals with SDB have distinct craniofacial morphology for which orthodontists are most suitable for the management due to their dental expertise.</p><p><strong>Aim: </strong>This study aims to discern key differences in dental parameters between individuals with and without SDB.</p><p><strong>Methods: </strong>The present study is a cross-sectional observational study conducted for 12 months. Out of 70 participants, 35 were placed in the SDB group as per the Berlin questionnaire (BQ) and 35 in the control aged 18-22 years. Criteria excluded individuals with preexisting illnesses, missing teeth, tonsillectomy, orthodontic or jaw surgeries, cleft lip/palate, or craniofacial anomalies. Dental assessments included interdental width, palatal vault depth and shape, molar relation, overjet, and overbite. In addition, self-perceived orthodontic treatment needs were evaluated as a secondary measure.</p><p><strong>Results: </strong>In the SDB group, interdental distances were significantly reduced in the canine, first premolars, second premolars, and molar regions by 2, 3, 4, and 1.8 mm, respectively. A noticeable V-shaped arch was observed. Overjet and overbite increased by 42.85% and 31.42%, respectively, with Class 1 malocclusion more prevalent than Class 2. The Berlin questionnaire identified 54.3% as high-risk SDB. The Index of Orthodontic Treatment Need-Esthetic Component (IOTN-AC) revealed that 68.6% of snoring participants required orthodontic treatment.</p><p><strong>Conclusion: </strong>Individuals with SDB exhibit a constricted maxilla and reduced interdental measurements, indicating a moderate risk. The Berlin questionnaire proves valuable in assessing SDB severity. Moreover, individuals displaying signs of SDB often present a high prevalence of orthodontic treatment needs, as indicated by the IOTN-AC.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"19 4","pages":"284-289"},"PeriodicalIF":2.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559696/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is chest tube omission safe for patients with primary spontaneous pneumothorax scheduled for video-assisted thoracoscopic surgery? 计划接受视频辅助胸腔镜手术的原发性自发性气胸患者省略胸管是否安全?
IF 2.1 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-01 Epub Date: 2024-10-03 DOI: 10.4103/atm.atm_45_24
Chang Wan Kim, Il Hwan Park, Chun Sung Byun

Aims: Primary spontaneous pneumothorax (PSP) is a sudden pleural disease predominantly affecting healthy adolescents and young adults, making it a prevalent thoracic disorder within this demographic. This study evaluated the necessity of preoperative chest tube insertion for PSP patients and reassessed current clinical practices.

Methods: We conducted a retrospective analysis of medical records for individuals aged 14-30 years diagnosed with PSP who underwent video-assisted thoracoscopic surgery (VATS) at Wonju Severance Christian Hospital from January 2016 to December 2022. Patients were categorized retrospectively into two groups based on their initial treatment: Those who had a chest tube inserted and those who did not. We collected and compared clinical data, including demographics, treatment specifics, and outcomes.

Results: The study included 128 PSP cases. There was no difference in preoperative clinical data between the two groups, and there were no differences in operation time, number of wedge resections, and number of mechanical pleurodesis. However, the use of single-port surgery was significantly higher in the nonchest tube group (P = 0.001). The nonchest tube group had a significantly shorter hospital stay (P < 0.001), attributed to the absence of preoperative chest tube insertions. There were no significant differences in postoperative complications or recurrence rates between the groups.

Conclusions: In young PSP patients, proceeding directly to VATS without prior chest tube insertion in stable individuals does not lead to serious complications or negatively affect outcomes. This approach may offer an effective alternative for PSP management.

目的:原发性自发性气胸(PSP)是一种突发性胸膜疾病,主要影响健康的青少年和年轻人,是这一人群中常见的胸腔疾病。本研究评估了 PSP 患者术前插入胸管的必要性,并重新评估了当前的临床实践:我们对 2016 年 1 月至 2022 年 12 月期间在原州 Severance 基督教医院接受视频辅助胸腔镜手术(VATS)的 14-30 岁确诊为 PSP 患者的病历进行了回顾性分析。根据患者的初始治疗情况,将其回顾性地分为两组:插入胸管的患者和未插入胸管的患者。我们收集并比较了临床数据,包括人口统计学、治疗细节和结果:研究包括 128 个 PSP 病例。两组患者的术前临床数据无差异,手术时间、楔形切除次数和机械性胸膜穿刺次数也无差异。不过,无胸管组使用单孔手术的比例明显更高(P = 0.001)。无胸管组的住院时间明显更短(P < 0.001),这是因为术前没有插入胸管。两组患者的术后并发症或复发率无明显差异:结论:对于年轻的 PSP 患者,在病情稳定的情况下直接进行 VATS 而不事先插入胸管不会导致严重的并发症,也不会对预后产生负面影响。这种方法可为 PSP 的治疗提供一种有效的替代方案。
{"title":"Is chest tube omission safe for patients with primary spontaneous pneumothorax scheduled for video-assisted thoracoscopic surgery?","authors":"Chang Wan Kim, Il Hwan Park, Chun Sung Byun","doi":"10.4103/atm.atm_45_24","DOIUrl":"10.4103/atm.atm_45_24","url":null,"abstract":"<p><strong>Aims: </strong>Primary spontaneous pneumothorax (PSP) is a sudden pleural disease predominantly affecting healthy adolescents and young adults, making it a prevalent thoracic disorder within this demographic. This study evaluated the necessity of preoperative chest tube insertion for PSP patients and reassessed current clinical practices.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of medical records for individuals aged 14-30 years diagnosed with PSP who underwent video-assisted thoracoscopic surgery (VATS) at Wonju Severance Christian Hospital from January 2016 to December 2022. Patients were categorized retrospectively into two groups based on their initial treatment: Those who had a chest tube inserted and those who did not. We collected and compared clinical data, including demographics, treatment specifics, and outcomes.</p><p><strong>Results: </strong>The study included 128 PSP cases. There was no difference in preoperative clinical data between the two groups, and there were no differences in operation time, number of wedge resections, and number of mechanical pleurodesis. However, the use of single-port surgery was significantly higher in the nonchest tube group (<i>P</i> = 0.001). The nonchest tube group had a significantly shorter hospital stay (<i>P</i> < 0.001), attributed to the absence of preoperative chest tube insertions. There were no significant differences in postoperative complications or recurrence rates between the groups.</p><p><strong>Conclusions: </strong>In young PSP patients, proceeding directly to VATS without prior chest tube insertion in stable individuals does not lead to serious complications or negatively affect outcomes. This approach may offer an effective alternative for PSP management.</p>","PeriodicalId":50760,"journal":{"name":"Annals of Thoracic Medicine","volume":"19 4","pages":"245-250"},"PeriodicalIF":2.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559698/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Thoracic Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1